Drug
Imnn 001
Imnn 001: highest development phase Phase 3, developed by Imunon. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Imunon
Trials
| Drug | Phase | Indication |
|---|---|---|
| IMNN-001 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer) NCT06915025 | Phase 3 | Epithelial Ovarian Cancer |
Latest
No recent events.
Follow Imnn 001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.